⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Cosmo Clinical Research and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Cosmo Clinical Research
↗Puducherry, India
Cosmo Clinical Research is a specialized Contract Research Organization (CRO) based in India, focusing on bioequivalence (BA/BE) studies for generic drug development. The company provides end-to-end clinical research solutions, including clinical trial management, bioanalytical services, pharmacovigilance, and regulatory affairs support.
Operating out of Puducherry and Chennai, the firm maintains clinical and bioanalytical infrastructure designed to meet industry standards for emerging markets. They cater to pharmaceutical sponsors looking for cost-effective, high-quality research services with faster turnaround timelines for healthy volunteer bioequivalence studies.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2022
Ownership:private
Status:operating
FUNDING
Stage:Unfunded
Total Raised:$0
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
Competitors:Nordic Bioscience, BioAgilytix, Solvias
LEADERSHIP
Key Executives:
Olaganathan Arumugam - Designated Partner
LINKS
Website:cosmocr.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Cosmo Clinical Research. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.